181 related articles for article (PubMed ID: 24811691)
21. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
22. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
23. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
[No Abstract] [Full Text] [Related]
24. Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment.
Tong HV; Song le H; Hoan NX; Cuong BK; Sy BT; Son HA; Quyet D; Binh VQ; Kremsner PG; Bock CT; Velavan TP; Toan NL
BMC Infect Dis; 2015 Jan; 15():25. PubMed ID: 25626490
[TBL] [Abstract][Full Text] [Related]
25. Omega-6-derived oxylipin changes in serum of patients with hepatitis B virus-related liver diseases.
Lu Y; Fang J; Zou L; Cui L; Liang X; Lim SG; Dan YY; Ong CN
Metabolomics; 2018 Jan; 14(3):26. PubMed ID: 30830341
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
27. Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
Lee Y; Park US; Choi I; Yoon SK; Park YM; Lee YI
Clin Cancer Res; 1998 Jul; 4(7):1711-7. PubMed ID: 9676846
[TBL] [Abstract][Full Text] [Related]
28. The Expressions of CD44, CD90 and Alpha Fetoprotein Biomarkers in Indonesian Patients with Advanced Liver Disease: an Observational Study.
Mustika S; Wijaya H; Pratomo B
Acta Med Indones; 2019 Apr; 51(2):137-144. PubMed ID: 31383828
[TBL] [Abstract][Full Text] [Related]
29. Low Frequency of Peripheral Lymphocyte in Chronic Hepatitis B Patients Predicts Poor Progression to Hepatocellular Carcinoma.
Li J; Li J; Bao Y; Pan K; Lin X; Liu X; Wang H; Xu Y; Luo X; Li H; Duan C
J Clin Lab Anal; 2016 May; 30(3):208-15. PubMed ID: 25600684
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
[TBL] [Abstract][Full Text] [Related]
31. Association of genetic variation in B-cell activating factor with chronic hepatitis B virus infection.
Han Q; Yang C; Li N; Li F; Sang J; Lv Y; Zhao W; Li C; Liu Z
Immunol Lett; 2017 Aug; 188():53-58. PubMed ID: 28627389
[TBL] [Abstract][Full Text] [Related]
32. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
Yu F; Lu Z; Chen B; Dong P; Zheng J
Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
[TBL] [Abstract][Full Text] [Related]
35. The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases.
Jiang Z; Wang S; Jin J; Ying S; Chen Z; Zhu D; Xiao B; Hu Y; Qian Y; Cai T; Fu L
J Clin Lab Anal; 2020 May; 34(5):e23200. PubMed ID: 31916309
[TBL] [Abstract][Full Text] [Related]
36. [Detection and evaluation of serum GP73, a resident Golgi glycoprotein, as a marker in diagnosis of hepatocellular carcinoma].
Zhao XY; Li N; Ding HG; Jiang FF
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):943-5. PubMed ID: 21223806
[TBL] [Abstract][Full Text] [Related]
37. Association of serum soluble human leukocyte antigen-G levels with chronic hepatitis B virus infection.
Han Q; Li N; Zhu Q; Li Z; Zhang G; Chen J; Lv Y; Wang Y; Liu Z; Hao C
Clin Exp Med; 2014 Feb; 14(1):35-43. PubMed ID: 23007926
[TBL] [Abstract][Full Text] [Related]
38. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
[TBL] [Abstract][Full Text] [Related]
39. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
[TBL] [Abstract][Full Text] [Related]
40. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
